Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 1
Submit an article Journal homepage
1,826
Views
3
CrossRef citations to date
0
Altmetric
Coronavirus

Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents

Pio Lopeza Centro de Estudios en Infectología Pediátrica, Universidad Del Valle Clínica Imbanaco, Cali, ColombiaView further author information
,
Lulu Bravob College of Medicine, University of the Philippines Manila, Ermita, The PhilippinesView further author information
,
Erik Buntinxc Anima Research Center, Alken, BelgiumView further author information
,
Charissa Borja-Taborad Asian Hospital and Medical Center, Muntinlupa, PhilippinesView further author information
,
Hector Velasqueze Center of Attention in Medical Research (CAIMED), Bogotá, ColombiaView further author information
,
Edith Johana Rodriqueze Center of Attention in Medical Research (CAIMED), Bogotá, ColombiaView further author information
,
Camilo A. Rodriguezf Policlínico Social del Norte, Bogotá, ColombiaView further author information
,
Josefina Carlosg University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, The PhilippinesView further author information
,
May Emmeline B. Montellanoh Far Eastern University Hospital - Nicanor Reyes Medical Foundation, Quezon City, The PhilippinesView further author information
,
Edison R. Albertoi Tropical Disease Foundation-HIMC, Cavite City, The PhilippinesView further author information
,
Milagros Salvani-Bautistag University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, The PhilippinesView further author information
,
Yung Huangj Clover Biopharmaceuticals, Boston, MA, USAView further author information
,
Branda Huj Clover Biopharmaceuticals, Boston, MA, USAView further author information
,
Ping Lij Clover Biopharmaceuticals, Boston, MA, USAView further author information
,
Htay Htay Hanj Clover Biopharmaceuticals, Boston, MA, USAView further author information
,
Carmen Baccarinij Clover Biopharmaceuticals, Boston, MA, USAView further author information
&
Igor Smolenovj Clover Biopharmaceuticals, Boston, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7075-9827View further author information
ORCID Icon show all
Article: 2206359 | Received 24 Feb 2023, Accepted 19 Apr 2023, Published online: 25 May 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.